14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $10.49 $17.04 Thursday, 25th Apr 2024 ALXO stock ended at $16.87. This is 4.01% more than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 8.13% from a day low at $15.74 to a day high of $17.02.
90 days $10.49 $17.42
52 weeks $3.94 $17.42

Historical ALX Oncology Holdings Inc. prices

Date Open High Low Close Volume
Apr 25, 2024 $16.05 $17.02 $15.74 $16.87 495 377
Apr 24, 2024 $15.59 $16.25 $15.24 $16.22 436 599
Apr 23, 2024 $14.35 $15.76 $14.12 $15.50 438 556
Apr 22, 2024 $15.60 $15.66 $13.90 $14.23 286 920
Apr 19, 2024 $15.60 $16.15 $15.43 $15.60 470 298
Apr 18, 2024 $16.09 $16.15 $15.08 $15.74 656 220
Apr 17, 2024 $14.60 $17.04 $14.60 $16.08 2 018 968
Apr 16, 2024 $12.83 $14.61 $12.83 $14.49 1 546 147
Apr 15, 2024 $13.10 $13.10 $12.12 $12.89 325 439
Apr 12, 2024 $13.32 $13.63 $12.52 $13.03 355 706
Apr 11, 2024 $12.01 $13.71 $11.80 $13.38 571 436
Apr 10, 2024 $12.02 $12.23 $11.74 $12.05 448 732
Apr 09, 2024 $12.56 $12.70 $11.80 $12.34 436 868
Apr 08, 2024 $12.42 $12.80 $12.10 $12.14 886 322
Apr 05, 2024 $11.14 $12.30 $10.99 $12.23 915 503
Apr 04, 2024 $11.03 $11.29 $10.74 $11.24 297 388
Apr 03, 2024 $10.74 $10.97 $10.49 $10.80 313 563
Apr 02, 2024 $11.25 $11.25 $10.55 $10.72 371 880
Apr 01, 2024 $11.25 $11.44 $10.65 $11.02 518 742
Mar 28, 2024 $11.45 $11.45 $10.60 $11.15 1 052 159
Mar 27, 2024 $11.61 $11.66 $10.95 $11.41 197 173
Mar 26, 2024 $11.85 $11.89 $11.17 $11.19 254 568
Mar 25, 2024 $11.75 $12.17 $11.50 $11.72 268 811
Mar 22, 2024 $12.05 $12.37 $11.51 $11.74 515 191
Mar 21, 2024 $12.24 $12.69 $12.04 $12.51 580 625
Click to get the best stock tips daily for free!

About ALX Oncology Holdings Inc.

ALX Oncology Holdings. ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hodgkin's lymphoma, as well as a range of solid tumor indications, including head and neck squamous cell c... ALXO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT